On the first day Noland Arbaugh used his Neuralink implant, he broke a world record. Not a personal record — a world record for speed and precision in brain-computer interface cursor control, set in 2017 by a device that had taken years to refine. He broke it on day one, with a chip that had been implanted in his skull eight days earlier.
He was lying in bed, paralysed below the shoulders, thinking about moving a cursor. And the cursor moved.
"It blew my mind," he said later. "I genuinely didn't believe it was going to work that well, that fast."
What Noland Arbaugh's story tells us is not just that brain-computer interfaces work — we knew that, at research-lab scale, for years. What it tells us is that they are beginning to work well enough, reliably enough, and comfortably enough to rebuild a life around. That is a different claim entirely, and a far more significant one.
Before
The diving accident happened in 2016. Noland was 22. A shallow-water dive, the kind of mistake that takes a fraction of a second and rearranges a life permanently. The spinal cord injury left him paralysed from the shoulders down — no hand control, no independent movement of limbs, a level of physical dependence that required constant care for everything from getting out of bed to eating.
He was living with family, managed by a care routine, largely confined to a bed and a wheelchair. He played video games — one of the few activities that, with the right adaptive technology, was still partially accessible — but even that required workarounds and help. He described the years of paralysis with characteristic frankness: you lose a version of yourself, and then you spend years figuring out who you are after that loss.
In late 2023, he applied to participate in Neuralink's PRIME clinical trial — Precise Robotically Implanted Brain-Computer Interface. He was selected. On January 28, 2024, he became the first human being to receive Neuralink's N1 implant.
What Neuralink Actually Does
🧠 The N1 Implant — How It Works
The N1 chip is a coin-sized device implanted in the motor cortex — the region of the brain responsible for planning and initiating movement. It is inserted by a purpose-built robotic surgical system that places the device with a precision no human surgeon could match.
From the implant, 64 ultra-flexible threads — thinner than a human hair — extend into the surrounding brain tissue, carrying a total of 1,024 electrodes. These electrodes record the electrical activity of individual neurons as they fire. When you intend to move your hand, specific patterns of neural firing occur in the motor cortex. The N1 chip reads those patterns in real time and translates them into computer commands.
No movement is required. No muscle twitch, no eye gaze, no physical gesture. The system reads the signal that precedes movement — the intention — and acts on it. The interface is as close to pure thought control as any system that has ever existed outside of science fiction.
On Noland's first day of use, the system worked well enough for him to play online chess against opponents who had no idea they were losing to a man controlling a cursor with his motor cortex. It worked well enough for him to beat the 2017 world record for BCI speed. And it worked well enough that he wanted to use it again — which, in clinical trials of complex medical devices, is not a given.
The Wobble
Not everything went smoothly. Several weeks after the implant, Neuralink disclosed that some of the ultra-fine electrode threads had retracted from the brain tissue — a known risk with any neural implant, caused by micromotion as the brain naturally moves within the skull. The retraction reduced the number of active electrodes and caused a significant drop in performance. The world-record speed was gone. The fluid control was gone. Noland described the frustration of losing something he had only just found.
⚠ The Thread Retraction Problem
Thread retraction is one of the central challenges in long-term neural implant design. The brain is not a static organ — it moves, and the tissue around an implant undergoes an inflammatory response (gliosis) that can push flexible electrodes away from the neurons they were recording. This is an industry-wide challenge, not unique to Neuralink, and different teams are pursuing different solutions: softer materials, drug-coated threads to reduce inflammation, mesh electronics that conform to brain surface curvature.
For Noland, the practical consequence was that much of what he had gained felt temporarily lost. Neuralink's engineers responded by recalibrating the algorithms — teaching the decoder to extract clean signals from the remaining active electrodes. Performance was substantially restored.
This is the part of the story that matters beyond Noland specifically: the recalibration worked. The system adapted to a degraded hardware situation and recovered meaningful function. That is evidence of a maturing technology — not one that works perfectly from the start, but one that can be tuned, adjusted, and improved without requiring further surgery.
Eighteen Months In
By August 2025, Noland described his life with a specificity that made the transformation concrete. He was using the Neuralink device for approximately ten hours a day. Not for single tasks in controlled settings, but for the full range of what a person does with a computer: studying, reading, gaming, scheduling appointments, communicating.
"I have potential again. I feel like I'm growing — not just surviving."
— Noland Arbaugh · Fortune Magazine · August 2025The specifics of what his life looks like now:
Education
Enrolled in a neuroscience degree. Using the Neuralink to study the very technology implanted in his own brain.
Business
Started his own company. The degree of independence required to run a business was inaccessible before the implant.
Travel
Traveled to Paris and multiple US cities. The portability of the system — no external wires, no lab required — makes this possible.
Gaming
Plays games that were inaccessible before, with cursor control fast enough to be competitive. It was the first thing he tried, and it worked.
He described the experience of using the device not as one of managing a disability, but of regaining agency. There is a meaningful difference between the two. Adaptive technology for paralysis, historically, has meant workarounds — eye-gaze systems, sip-and-puff controls, voice recognition — that require significant cognitive overhead to translate intent into action. What Noland describes is something closer to the opposite: a system that is now so natural that he sometimes forgets it is there.
The Bigger Picture
Neuralink's PRIME trial has now enrolled nine participants — eight after Noland, including the first woman to receive the implant. The trial has expanded to clinical sites in the United States, Canada, the United Kingdom, and the United Arab Emirates. Each new participant generates data that refines the algorithms, informs the hardware design, and builds the evidence base that will eventually be required for regulatory approval at scale.
The field is moving fast, and Neuralink is not alone. Synchron, a competitor backed by Jeff Bezos and Bill Gates, uses a stent-based approach that does not require opening the skull — instead threading the device through the jugular vein to the motor cortex, where it unfolds and records neural signals through the blood vessel wall. BrainGate, the long-running academic consortium at Brown University, has been studying BCIs in paralysed patients since the early 2000s and has decades of published data on long-term performance and safety.
The convergence of better materials science, miniaturised wireless electronics, and AI-trained neural decoders is making all of these approaches viable at a speed that would have seemed implausible a decade ago. The same advances in signal processing and machine learning that are reshaping drug discovery and climate modelling are reshaping the brain-machine boundary.
🔮 What Comes Next
The near-term roadmap for neural interfaces extends well beyond cursor control. Neuralink's stated goal includes enabling people to control prosthetic limbs with direct brain signals — bypassing the spinal cord injury entirely, rather than routing around it through a computer. Their longer-term ambitions include bidirectional interfaces that not only read motor signals but deliver sensory feedback, recreating the sense of touch through targeted neural stimulation.
Further out: restoration of speech for people with ALS, locked-in syndrome, or stroke-related aphasia. Memory augmentation. Direct human-AI communication interfaces that bypass the bottleneck of typing and speaking.
Each of these is further from clinical availability than cursor control. But Noland's results — achieved not in a research lab but in daily life, on a ten-hour-a-day schedule, across eighteen months — suggest that the foundation is more solid than the sceptics expected.
The hardest question these technologies raise is not technical but distributive: who gets access, and when? The PRIME trial is, by necessity, small and selective. The path from nine participants to widespread clinical deployment involves years of safety data, regulatory review, manufacturing scale-up, and reimbursement decisions that will determine whether this becomes a technology for everyone with paralysis, or a technology for those with the resources to access cutting-edge trials.
Noland Arbaugh is spending ten hours a day answering that question from the inside — providing the data, demonstrating the real-world viability, and making the argument through his own life that the investment is worth making.
He is studying neuroscience now. He is, quite literally, learning the science of what is happening inside his own skull. There is something fitting about that: the first mind online, trying to understand how it got there.
Sources & Further Reading
- Metz, C. (2025). "Neuralink's first study participant says his whole life has changed." Fortune.
- Euronews Next (2024). "People think it's like the Matrix: Neuralink's first patient on having a brain chip."
- Wikipedia. Noland Arbaugh. Neuralink's first human implant recipient.
- Neuralink (2024). PRIME Study — Precise Robotically Implanted Brain-Computer Interface. ClinicalTrials.gov NCT05948fonti.
- Salatino, J.W., Ludwig, K.A., Kozai, T.D.Y. & Bhatt, D.L. (2017). Glial responses to implanted electrodes in the brain. Nature Biomedical Engineering, 1, 862–877.
- Collinger, J.L. et al. (2013). High-performance neuroprosthetic control by an individual with tetraplegia. The Lancet, 381(9866), 557–564.
- Oxley, T.J. et al. (2021). Motor neuroprosthesis implanted with neurointerventional surgery improves capacity for activities of daily living tasks in severe paralysis. Journal of NeuroInterventional Surgery, 13(2), 102–108.
Buy me a coffee